Council: Sunscreen Efficacy Ceiling Is More Harmful Than SPF Claim Limit
This article was originally published in The Rose Sheet
Executive Summary
FDA should not impose an efficacy ceiling on sunscreen formulations even if it caps sun protection factor label claims at 50 or 50+, industry stakeholders argue.
You may also be interested in...
FDA Considers Capping SPF Values At 50+ Despite Efficacy Data
FDA might cap sun-protection factors at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.